Back
INmune Bio, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
27
INMB
INmune Bio, Inc.
Last Price:
$1.84
Seasonality Move:
-28%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiINmune Bio, Inc. Stock Forecast
-
Is INmune Bio, Inc. Stock Undervalued?The current INmune Bio, Inc. [INMB] share price is $1.83. The Score for INMB is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
INMB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will INmune Bio, Inc. Stock Go Up Next Year?
Data Unavailable
INmune Bio, Inc. Stock Rating
Data Unavailable
INmune Bio, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
inmunebio.com
52-Week Data
52-Week High:
11.64
52-Week Low:
1.38
Prediction Charts
Market Cap:
48.7M
Price in USD:
1.83
Volume:
155.7K
Beta:
1.66
Technical Analysis
SMA50:
1.77
SMA100:
1.99
SMA200:
4.26
52-Wk Change:
-63.25%
Stock Predictions
-
Is INmune Bio, Inc. stock public?Yes, INmune Bio, Inc. is a publicly traded company.
-
What is the INmune Bio, Inc. stock quote today?The INmune Bio, Inc. stock price is 1.83 USD today.
-
How to buy INmune Bio, Inc. stock online?You can buy INmune Bio, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-28 | 1.68 | 1.74 | 1.75 | 1.61 |
| Dec-1 | 1.73 | 1.57 | 1.75 | 1.53 |
| Dec-2 | 1.60 | 1.57 | 1.60 | 1.54 |
| Dec-3 | 1.56 | 1.76 | 1.79 | 1.54 |
| Dec-4 | 1.74 | 1.88 | 1.92 | 1.69 |
| Dec-5 | 1.85 | 1.91 | 1.92 | 1.81 |
| Dec-8 | 1.89 | 2.04 | 2.07 | 1.89 |
| Dec-9 | 2.04 | 2.17 | 2.26 | 2.02 |
| Dec-10 | 2.14 | 2.23 | 2.25 | 2.11 |
| Dec-11 | 2.22 | 2.14 | 2.30 | 2.13 |
| Dec-12 | 2.15 | 2.01 | 2.19 | 2.01 |
| Dec-15 | 2.02 | 1.91 | 2.02 | 1.86 |
| Dec-16 | 1.85 | 1.89 | 1.95 | 1.82 |
| Dec-17 | 1.91 | 1.83 | 1.94 | 1.82 |
INmune Bio, Inc. Earnings
Data Unavailable
INmune Bio, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $0.33 per share.
* INmune Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.